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ABSTRACT 15 
Background 16 
Antimicrobial resistance is becoming a major threat to public health and there is much current 17 
activity to ameliorate that threat. However, the relative contributions that potential sources of 18 
antimicrobial resistant (AMR) bacteria represent are not well established. Over-prescription of 19 
antimicrobials by clinicians is one source of selection for AMR bacteria/genes, but antimicrobials are 20 
used in greater quantities in food production. These bacteria/genes can then reach humans via food, 21 
the environment, or other means. 22 
Scope and approach 23 
Summarised in this review are potential transmission routes of AMR bacteria/genes from 24 
agricultural production to human infections. The situation is complicated, and it is difficult to 25 
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compare studies because of different methodologies and definitions of resistance being used. Data 26 
and examples to illustrate each transmission route are provided where available. 27 
Key findings and conclusions 28 
Quantitative data for defined organism/phenotype/gene combinations for exposure assessment are 29 
rare. Another problem is the identification of indistinguishable AMR bacteria in foods and human 30 
cases, which is invariably taken to show that food consumption is a source of infections. However, 31 
these data do not show the direction in which the flow of the organism/gene occurred nor do they 32 
rule out another source(s), and such data are scant. Case control studies could identify food 33 
exposures associated with particular organism/gene infections. The construction of models 34 
representing potential transmission pathways may help to reveal their relative contributions. 35 
However, the data may not be available to support these models. The lack of coherent data hampers 36 
the development of effective policy.  37 
 38 
Keywords. Antimicrobial resistance; food; agriculture; transmission; environment: societal drivers 39 
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1 Introduction 44 
The discovery and introduction of antibiotics prior to the Second World War marked a pivotal point 45 
in the ability of humanity to combat bacterial infections. Formerly life-threatening infections became 46 
easily treatable, although the oft-quoted comment by a US surgeon general “it is time to close the 47 
book on infectious diseases, and declare the war against pestilence won” appears to be an urban 48 
myth (Spellberg & Taylor-Blake, 2013). However, ever since the discovery of antibiotics, the 49 
phenomenon of antimicrobial resistance (AMR) has been recognised (Davies & Davies, 2010) and in 50 
1945 Sir Alexander Fleming warned of the potential for AMR to become a public health threat “then 51 
there is the danger that the ignorant man may easily under dose himself and by exposing his 52 
microbes to non-lethal quantities of the drug make them resistant”1 . Of concern is the fact that 53 
AMR can readily be transmitted from bacterium to bacterium on segments of DNA by several means 54 
including phages, transposons and plasmids, so resulting in horizontal gene transfer (HGT) 55 
(Djordjevic, Stokes, & Chowdhury, 2013). The three predominant processes at play include “the 56 
emergence, invasion and occupation” (Baquero, Lanza, Cantón, & Coque, 2015) of environments, 57 
this process involving mobility in both bacteria and the genes themselves. HGT has been shown to 58 
occur in the environment, food (Jahan & Holley, 2016) and the gastrointestinal tract. These 59 
environments also act as reservoirs of AMR genes - the “resistome” (Forsberg, et al., 2012).  60 
The emergence of AMR in clinically important bacteria has continued at the same time as 61 
the pipeline of new antibiotics has dwindled to the point where phrases such as “we are in the midst 62 
of an emerging crisis of antibiotic resistance for microbial pathogens in the United States and 63 
throughout the world” are appearing in the literature (Spellberg, et al., 2008). There are claims that 64 
AMR infections have been increasing, for example for Salmonella (Su, Chiu, Chu, & Ou, 2004), but 65 
                                                            
1 http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf  
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the data are patchy, complex and come from countries with different surveillance systems. A recent 66 
report from Canada indicates currently stable and, in some cases, decreasing incidences of AMR 67 
infections (Public Health Agency of Canada, 2016). In the UK the number of methicillin-resistant 68 
Staphylococcus aureus (MRSA) bacteraemia cases reduced by 81% from 2007/8 to 2012/13 but, in 69 
contrast, the number of isolates of carbapenemase-producing Enterobacteriaceae increased 70 
approximately ten fold between 2009 and 2014 (Department of Health antimicrobial resistance 71 
strategy analytical working group, 2016). This group of organisms is rated as “Priority 1: critical” for 72 
development of new antibiotics2. A similar increasing trend has been identified for Klebsiella 73 
pneumoniae in wider Europe, and resistance to third generation cephalosporins in Escherichia coli is 74 
also increasing (European Centre for Disease Prevention and Control, 2016). A comparison between 75 
the USA, Kuwait and China between 1994 and 2000 found a growth in AMR infections of 6, 17 and 76 
22%, respectively, over the period. Looking to the future the “O’Neill report” predicts 10 million lives 77 
lost per year in 2050 because of AMR bacteria (O'Neill, 2016). 78 
The term “antimicrobial” has a number of meanings, but in this review it is taken to mean 79 
antibiotics (small compounds produced by one organism that kills or inhibits another) and their 80 
chemical derivatives. There are many such chemicals and a categorization with some examples is 81 
provided in Table 1. 82 
……………………………. 83 
Table 1 about here 84 
…………………………… 85 
 86 
2 Development and transmission of AMR bacteria in Agri-food 87 
settings 88 
2.1 Use of antimicrobials in the agri-food chain 89 
Antimicrobials are used for various purposes in animal production: 1) therapeutic treatment of 90 
diseased animals, 2) growth promotion, 3) treating a group of animals to combat disease in a 91 
                                                            
2 http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf  
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proportion of them and to prevent disease from occurring in the rest (metaphylaxis) and, 4) use 92 
during periods of high susceptibility to infections (prophylaxis). Of these, the use of antimicrobial 93 
growth promoters (AGPs) has been banned in the EU since 2006 (http://eur-lex.europa.eu/legal-94 
content/EN/ALL/?uri=CELEX:32003R1831 ), and the cessation of AGP use is frequently suggested in 95 
the literature as a means of reducing or stabilising AMR bacteria. In the US medically important 96 
antimicrobials which are used in feed or water stopped being available over the counter at the end 97 
of 20163. The benefits of using AGPs are not clear and might only be realised when sub-optimal 98 
hygiene conditions prevail (Rushton, 2015), or at early stages of production, although Hao, et al. 99 
(2014) report data tending to show increased productivity with AGP use. An evaluation of the use of 100 
AGPs in less affluent countries concluded that there would be “negligible effects in these countries” 101 
at the national level on pork and chicken production if the use of AGPs were to be discontinued 102 
(Angulo, Collignon, Wegener, Braam, & Butler, 2005). The reasons for this included likely small 103 
decreases in production resulting from cessation of use of AGPs and the minor contribution that 104 
meat protein makes to the diet of the poor, although this is increasing in many low to middle income 105 
countries for those with increasing disposable income. A study of broiler chickens in Denmark 106 
reported that the feed conversion rate increased slightly after the withdrawal of AGPs (Emborg, 107 
Ersbøll, Heuer, & Wegener, 2001) suggesting that their use would, in fact, represent an economic 108 
cost. 109 
The risks and benefits of AGP use are still being debated (Hao, et al., 2014; Phillips, 2007). 110 
However, antimicrobials are necessary for the prevention and treatment of diseases in production 111 
animals with accompanying benefits to animal welfare. There may also be an effect in reducing 112 
zoonotic diseases and environmental impacts such as methane production both in the growing 113 
animal (by using monensin, for example) and in animal waste. 114 
 115 
2.1.2 Antimicrobial usage 116 
                                                            
3 https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm507355.htm  
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 117 
A recent survey reported on the veterinary use of antimicrobials in the EU broken down in to 118 
antimicrobial class and the disease that they were being used to treat (De Briyne, Atkinson, 119 
Pokludová, & Borriello, 2014). As an example, 40% of the citations of use of antimicrobials in cattle 120 
and calves were for the control of mastitis, and for 78% of the time non-critically important 121 
antimicrobials were used. Lists of critically important antimicrobials are available for veterinary4 and 122 
human clinical5 perspectives. In China an estimated 38.5 million kg of antimicrobials were used in 123 
pork and poultry production in 2012 (Krishnasamy, Otte, & Sibergeld, 2015). Estimates of the change 124 
in demand for antimicrobials for animal production indicates an increase of 67% from 2010 until 125 
2030, driven largely by the intensification of animal production systems in emerging economies (Van 126 
Boeckel, et al., 2015). In Brazil, China, Russia, India and South Africa, the increase is predicted to be 127 
99%. The ban on the use of AGPs in the EU did not necessarily result in a reduction of the veterinary 128 
use of antibiotics overall for the period 2005-2009 (Woolhouse, Ward, van Bunnik, & Farrar, 2015). 129 
The MARAN 2007 report noted an increase in the use of antimicrobials in the Netherlands and 130 
ascribed, in part, to a possible “substitution of growth promoters” implying continued use of 131 
antimicrobials in another guise, e.g. prophylaxis (Veterinary Antibiotic Usage and Resistance 132 
Surveillance Working Group, 2009). However, more recent data for the Netherlands suggest a slight 133 
reduction in sales of antimicrobials6 between 2014 and 2015 at almost one third of the 2007 134 
volumes. 135 
Within the EU there are marked differences in the volume of antimicrobials used for animal 136 
production when normalised on a mg/kg biomass basis (Grave, Torren-Edo, & Mackay, 2010). In a 137 
study of ten European countries (Netherlands, France, United Kingdom, Czech Republic, Switzerland, 138 
Germany, Denmark, Finland, Sweden and Norway), usage in France and the Netherlands was 139 
substantially higher (more than two fold) compared to the other eight countries and around ten 140 
                                                            
4 http://www.oie.int/fileadmin/Home/eng/Our_scientific_expertise/docs/pdf/Eng_OIE_List_antimicrobials_May2015.pdf  
5 http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf 
6 http://www.wur.nl/upload_mm/0/b/c/433ca2d5-c97f-4aa1-ad34-a45ad522df95_92416_008804_NethmapMaran2016+TG2.pdf  
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times the amounts used in Norway. Several potential reasons for these differences were listed, but 141 
differences of proportions of the animals produced (dairy cattle, cattle, poultry and pigs) was 142 
excluded.  143 
The distribution of antimicrobials sold for veterinary use compared to those prescribed for 144 
human use in England is shown in Figure 1 (data from (Public Health England, 2015). Some major 145 
differences were observed, for example penicillins, fluoroquinolones and 1st and 2nd generation 146 
cephalosporins were used in greater proportions for human therapy, while the opposite is true for 147 
tetracyclines, sulphonamides and trimethoprim, and lincosamides. Glycopeptides and 148 
monobactams/carbapenems were not sold for veterinary use. 149 
………………………………. 150 
Figure 1 about here 151 
……………………………….. 152 
 153 
2.2 AMR bacteria and antimicrobials in meat and dairy production 154 
2.2.1 Occurrence of AMR bacteria during production 155 
 156 
There is evidence that the provision of antimicrobials to livestock can result in the 157 
emergence of AMR bacteria. For example, in Canadian feedlot cattle the inclusion of 158 
chlortetracycline in the diets of calves resulted in the appearance of tetracycline-resistant C. jejuni 159 
(Inglis, et al., 2005). In American feedlot cattle, administration of tylosin selected for enterococci 160 
resistant to erythromycin and tylosin (Beukers, et al., 2015). This appeared to result from selection 161 
for strains already present in animals arriving at the feedlot, and resistance fell at around the time 162 
that tylosin was withdrawn prior to slaughter. The use of antimicrobials may also lead to the 163 
selection of resistant veterinary pathogens, for example Mannheimia haemolytica which causes 164 
bovine respiratory disease (Cameron & McAllister, 2016). 165 
Antibiotic resistant bacteria have been detected in farmed animals in many studies. For 166 
example, rectal swabs and faecal samples from farms in the US were tested for the presence of AMR 167 
Campylobacter (Bae, et al., 2005). The most prevalent resistance was to doxycycline (42.3%) and 168 
8 
 
lesser rates of resistance being found for erythromycin, nalidixic acid and ciprofloxacin. Most C. 169 
jejuni isolates (58.8%) were sensitive to all four antibiotics tested. Different results were obtained for 170 
C. coli where resistance was more prevalent, with 72.7% of isolates being resistant to one or more of 171 
these antimicrobials. This study also provided data which showed different levels of AMR bacteria 172 
with different kinds of farming practice. AMR bacteria, especially C. coli, were more prevalent in calf 173 
rearer farms. It was postulated that this may be caused by the greater use of antimicrobials in calf 174 
rearing. A generally higher level of resistance in C. coli compared to C. jejuni has been reported in 175 
other studies, e.g. in faecal isolates from US dairy cows (Englen, Hill, Dargatz, Ladely, & Fedorka-176 
Cray, 2007) and feedlot cattle (Englen, Fedorka-Cray, Ladely, & Dargatz, 2005). In human cases 177 
infections caused by C. jejuni are much more common than those caused by C. coli. 178 
A comparison was made between AMR Salmonella Dublin isolates from dairy and beef cattle 179 
in the US (Davis, et al., 2007). This serovar was selected as it is adapted to bovines so that any 180 
resistance acquired is most likely to have come from agricultural antimicrobial use rather than from 181 
human therapeutics. The two kinds of animal were selected as antimicrobial use with beef cattle is 182 
less than it is for dairy cattle. A problem with the study is that relatively few (19) beef isolates were 183 
obtained compared to 273 for dairy sources, but for all except one of the antimicrobials tested the 184 
prevalence of resistance was greater in the dairy isolates. The reported data therefore supported the 185 
hypothesis that the use of antimicrobials in dairy calf rearing results in the emergence of AMR S. 186 
Dublin. 187 
Quinolone-resistant Escherichia coli were isolated from animals and farm environments in 188 
Sweden. These organisms were isolated from 60% of calf and 28% of cow faecal samples, although 189 
there was considerable farm-to-farm variability (Duse, et al., 2016). A report of 2013 UK data 190 
provides information of antibiotic resistance of Salmonella, Campylobacter and E. coli  in veterinary 191 
isolates (Public Health England, 2015). 192 
A study of faecal isolates of Campylobacter from organic and conventional dairy herds in the 193 
USA was unable to identify a difference in AMR patterns between the two types of agricultural 194 
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practice (Sato, Bartlett, Kaneene, & Downes, 2004), although resistance to tetracycline was higher in 195 
calves than adult animals. However, an analysis of AMR E. coli from cows and calves showed that 196 
isolates from the organic farms were less resistant for seven antibiotics, but not for an additional 10 197 
(Sato, Bartlett, & Saeed, 2005).  Resistance was also reported to be lower in E. coli from the faeces of 198 
pigs from organic farms compared to those on conventional farms (Hoogenboom, et al., 2008), as 199 
was the case for E. coli and Ent. faecium in broilers. In contrast no difference could be found with 200 
conventional and organic poultry with respect to AMR in Campylobacter. 201 
A greater prevalence of AMR E. coli isolates in calves (81.5%) compared to beef cattle 202 
(39.2%) has been noted in Belgian data (Hanon, et al., 2015), and this is a common finding for a 203 
range of AMR bacteria (Sato, et al., 2004; Tenhagen, et al., 2014) reflecting the greater need to treat 204 
calves with antimicrobials. A comparison of veal, beef and dairy production reflected a large 205 
difference in AMR E. coli (Catry, et al., 2016) between intensively reared veal calves compared to 206 
dairy and beef animals and concluded that “intensively reared veal calves deserve special attention 207 
in antimicrobial resistance monitoring and intervention programmes”. 208 
AMR Salmonella have been isolated from lairage environments in the UK and this may 209 
present a means whereby resistant organisms are passed from day to day to different groups of 210 
animals at slaughter (Small, et al., 2006). Salmonella can survive for long periods under dry 211 
conditions such as might occur in dried faeces. In Spanish goat and lamb slaughtering operations, 212 
some evidence has been provided to suggest that resistant bacteria are primarily introduced with 213 
the animals, resistant spoilage organisms persist along the process but pathogens do not persist 214 
beyond the cutting room (Lavilla Lerma, Benomar, Casado Muñoz, Gálvez, & Abriouel, 2014; Lavilla 215 
Lerma, Benomar, Gálvez, & Abriouel, 2013). 216 
Low prevalence rates of AMR E. coli were found in wild deer and small mammals tested in 217 
Spain (Alonso, González-Barrio, Tenorio, Ruiz-Fons, & Torres, 2016). Similar results were obtained for 218 
white-tailed deer in the USA from 1999 to 2009 (Fitzgerald, Schooley, Berry, & Kaneene, 2011), and 219 
both studies suggest that carriage is lower where direct selection is minimal in wild animals. Data 220 
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form such sources could represent a baseline against which AMR in farmed animals could be 221 
measured. 222 
2.2.2 Linkages between agricultural use of antimicrobials and human infections 223 
 224 
It has been shown that indistinguishable strains of AMR bacteria have been found both in food 225 
isolates and human cases (Doi, et al., 2010; Kluytmans, et al., 2013; Leverstein-van Hall, et al., 2011), 226 
although the evidence is patchy and not necessarily consistent between countries (Wu, et al., 2013). 227 
For example, for gentamicin resistant Campylobacter it was concluded that chicken was not the only 228 
source of human clinical resistant strains (Zhao, et al., 2015), although poultry meat was the most 229 
likely source of resistant C. coli infections. The recovery of indistinguishable isolates of an AMR 230 
bacterium from two environments does not reveal the direction in which the transmission occurred 231 
(Singer & Williams-Nguyen, 2014). Evidence of a direction of flow from agriculture to humans is 232 
mounting from other sources and a case in point is the detection of plasmid-borne colistin-resistant 233 
E. coli in China (Liu, et al., 2016). This antibiotic is known as a “drug of last resort” (Al-Tawfiq, 234 
Laxminarayan, & Mendelson, 2017) and is used to treat otherwise intractable infections in humans, 235 
but also has use in the treatment of food animals. The fact that the resistant organism was much 236 
more frequent in the agricultural environment than in the human population suggests that the 237 
direction of transmission is environment to human, and not the other way round. A caveat is that 238 
colistin is manufactured in China and it is possible that effluent from the process may have passed 239 
into the environment, a phenomenon which has been reported for other antimicrobials in China and 240 
elsewhere (Larsson, 2014). 241 
Virginiamcyin, a streptogramin antimicrobial, was in use in livestock in the USA from 1975 242 
while quinupristin/dalfopristin, also streptogramins, started to be used to treat Vancomycin 243 
Resistant Enterococcal infections in 1999. However, a study published in 1999 (Moellering, et al.) 244 
reported the detection of resistant, but not “highly resistant”, strains which implies that resistance 245 
could have been caused by co-selection alongside virginiamycin resistance in agricultural production. 246 
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There is conflicting information as to the connection between antibiotic use in animals and 247 
the emergence of AMR in humans. For example the reduction in the use of avoparcin has been 248 
linked to a reduction of vancomycin-resistant enterococci (VRE) in the human population (Klare, et 249 
al., 2009). At a larger scale, an analysis of antimicrobial use and resistance for seven European 250 
countries including Denmark has revealed a correlation between the two (Chantziaras, Boyen, 251 
Callens, & Dewulf, 2014). Limited use of fluoroquinolones in Norwegian broiler production was 252 
found to be associated with low levels of fluoroquinolones in Norwegian broilers and humans 253 
becoming infected in Norway, in comparisons to humans infected abroad (Norström, et al., 2006). 254 
However, carbapenem-resistant salmonellae were isolated from poultry and pig farms in Germany 255 
even though this group of antimicrobials is not permitted for use in pig production (Fischer, et al., 256 
2013). This may have resulted from co-selection for another resistance determinant; co-selection of 257 
AMR bacteria has been described in the presence of heavy metals but less so for biocides (Wales & 258 
Davies, 2015). In addition, in the USA, a ban on the use of enrofloxacin in poultry production did not 259 
result in a reduction in ciprofloxacin resistance in chicken or human Campylobacter isolates (Food 260 
and Drug Administration, 2012). The potential for cattle to be a source of human S. Typhimurium 261 
DT104 infections has been argued against (Davis, et al., 1999) because of inter alia a lack of correct 262 
timing of the use of antimicrobials in the human population and use in animals, and the occurrence 263 
of S. Typhimurium DT104  in wildlife. 264 
 265 
2.2.3 Antimicrobials and the resistome in the environment 266 
 267 
Antimicrobials themselves can be detected in farming environments as a large proportion of those 268 
administered to animals may be excreted un-metabolised.  In China, testing of faecal samples from 269 
pigs, cows and chickens showed a prevalence range of 0 to 82.1% (chlortetracycline in cow faeces) 270 
and the highest concentration was 1420.76 mg enrofloxacin/kg chicken faeces (Zhao, Dong, & Wang, 271 
2010), which was the highest identified in a recent review (Wohde, et al., 2016). Such contaminated 272 
manure may then, in turn, be applied as a fertiliser to agricultural land and so released to soil and 273 
12 
 
water thus creating a greater variety of transmission routes from treated animal to humans. Wohde 274 
et al (2016) includes tables of similar data for various classes of antimicrobials and discussion as to 275 
their fate once excreted from the animal. Also in China, antimicrobials have been detected in animal 276 
wastewater, effluent and river waters (Wei, Ge, Huang, Chen, & Wang, 2011). Only one of 18 river 277 
water samples was free of any detectable antimicrobials.   278 
A study of AMR genes in historical samples of Danish soils which had been amended using 279 
manure or inorganic fertilisers showed found that four β-lactam AMR genes tended to increase only 280 
in the manured soils at about the same time as the relevant resistance was noted  in humans 281 
(Graham, Knapp, Christensen, McCluskey, & Dolfing, 2016). Their abundance ceased possibly in line 282 
with reductions in their agricultural use. However, another gene, int1 did not decrease and this may 283 
have been through co-selection as the concentration of copper increased. It was commented that 284 
we must be careful not to solve one problem by creating another. 285 
 286 
2.3 AMR bacteria in aquaculture 287 
Antimicrobials are not confined to use in the terrestrial agri-food chain, but also in 288 
aquaculture (Cabello, 2006). The similarities between both systems has been reviewed in respect to 289 
the development of AMR (Done, Venkatesan, & Halden, 2015). The industry has been associated 290 
with poor control of the use of antimicrobials and it has been said that this overuse was needed 291 
because of poor sanitary conditions in the industry, and this may be associated with the rapid 292 
increase in aquacultural production which has occurred over the last 30 years. For example, the 293 
production of Tilapia in China has increased from close to zero in 1986 to almost 1.4 x 106 tonnes in 294 
2010 (Rico, et al., 2013). If the trend towards increasing aquacultural production continues, then any 295 
problems connected with AMR will grow with the industry unless the pattern of antimicrobial usage 296 
changes, and there is evidence that it has been reducing in some areas (Rico, et al., 2013). The use of 297 
antimicrobials in aquaculture in Asia is highly variable, but 100% of Vietnamese Pangasius farms 298 
used antimicrobials, while prawn and shrimp farms in Bangladesh were infrequent users (Rico, et al., 299 
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2013). The emergence of AMR fish pathogens has been noted (Cabello, 2006) and the question as to 300 
the potential to spread AMR genes to humans raised. It is of note that the accumulation of 301 
tetracycline from water to plant to fish has been demonstrated experimentally (Boonsaner & 302 
Hawker, 2013). 303 
 304 
2.4 AMR bacteria and antimicrobials in vegetable production 305 
Fruits and vegetables can also be treated with antibiotics and so potentially result in AMR 306 
selection among their natural microflora, and other forms of exposure to AMR bacteria may occur 307 
during irrigation as well as application to crops of manures derived from animals exposed to 308 
antimicrobials (Schwaiger, Helmke, Hölzel, & Bauer, 2011). In the United States in 2009 16,465 kg of 309 
antimicrobials were applied to orchards, and this represented 0.12% of those used in animal 310 
production (Stockwell & Duffy, 2012). In a Chinese study, antimicrobials were reported to be higher 311 
in organic than conventional vegetables, presumably because the organic vegetables were fertilised 312 
with animal-derived manure (Hu, Zhou, & Luo, 2010). The addition of manure to soils has been 313 
shown to enrich AMR bacteria but with no resultant increase in accumulation of AMR bacteria in the 314 
vegetables themselves (Marti, et al., 2013) compared those grown in soils which had never received 315 
manure. Composting and mandated offset periods were proposed as means of minimising exposure 316 
of the population to AMR bacteria from vegetables. 317 
Some information on the effects of agricultural uses of antimicrobials is provided by 318 
comparisons of food produced under conventional and organic practices. A study of lettuces in Costa 319 
Rica concluded that the organic status of one of ten farms studied “had little, if any, effect on the 320 
antimicrobial resistant communities” (Rodríguez, et al., 2006). This was explained either by the AMR 321 
communities identified being natural, or because the organic farm had previously been exposed to 322 
antimicrobials. Similarly, there were no differences in prevalence or concentration of AMR bacteria 323 
detected in French organic and conventional fruits and vegetables (Ruimy, et al., 2010). Produce 324 
growing in or on the soil was more frequently contaminated than produce growing above the soil. It 325 
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was concluded that the AMR bacteria present in the food were environmental, and that the foods 326 
“do not constitute a direct threat of infection of the general population”. This situation contrasts 327 
with the data for organic and conventional animal production. 328 
 329 
3 Transmission routes from food production to humans 330 
Essentially there are three transmission routes of AMR bacteria from agri-food systems to 331 
humans 1) the consumption of contaminated food 2) contact between humans and treated animals 332 
or 3) environmental contamination (which can also be of the antimicrobial itself). All would be 333 
classed as zoonotic transmission routes. Complicating the picture is HGT and consideration needs to 334 
be given to both bacteria and the genes that they carry. In addition, not all of the AMR bacteria 335 
which need to be assessed are conventional foodborne pathogens, as some are commensals (normal 336 
microflora) which may nevertheless act as a means of transmitting AMR genes and causing 337 
infections in humans. The importance of the role of commensals in linking different parts of the 338 
biosphere has been emphasised (Djordjevic, et al., 2013). An example is the VRE which are not 339 
usually regarded as foodborne pathogens yet can cause wound infections and septicaemia. 340 
Enterococci may acquire their resistance following the use of avoparcin in the production of poultry 341 
as avoparcin and vancomycin are structurally similar, although the common belief  of such a link is 342 
not unequivocal (Phillips, et al., 2004). 343 
 344 
3.1 Direct Food Consumption 345 
The relative contribution between human and veterinary/food production use of 346 
antimicrobials in the emergence of human clinical AMR infections is not known (Singer & Williams-347 
Nguyen, 2014). Even less is known about the proportionate role of foods containing AMR bacteria 348 
which may potentially be introduced accidentally during food production, from intentionally added 349 
bacteria such as lactic acid bacteria starter cultures (Aarts & Margolles, 2014), or cross 350 
contamination during processing. 351 
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Foodborne pathogens may themselves harbour mobile resistance genes, for example tetM, 352 
ermB and IS1542 in L. monocytogenes (Gelbíčová, Pantůček, & Karpíšková, 2016; Haubert, 353 
Mendonça, Lopes, de Itapema Cardoso, & da Silva, 2016; Yan, et al., 2010). Such resistance can be at 354 
a very low prevalence amongst isolates tested, for example 2% of 204 French isolates (Granier, et al., 355 
2011). where resistance to tetracycline, cotrimoxazole and erythromycin was recorded. In addition 356 
spoilage and commensal organisms may also be resistant (Toomey, Bolton, & Fanning, 2010). 357 
A study of virulence factors in AMR and non-AMR E. coli isolates from poultry, healthy 358 
vegetarians and hospital inpatients found that the human resistant strains were more like the 359 
poultry resistant and sensitive strains than human sensitive strains (Johnson, et al., 2007). Strains 360 
from the vegetarians were more like those from the poultry, and this group would not have been 361 
directly exposed to the food. It is possible that the E. coli was passed on to them by a family member 362 
or other meat-eating contact.  363 
A Finnish study concluded that the Enterobacteriaceae in vegetables were different from 364 
those of the human faecal flora with respect to their AMR profiles and concluded that these 365 
organisms did not “contribute substantially” to high levels of AMR organisms in the human faecal 366 
flora (Österblad, Pensala, Peterzéns, Heleniusc, & Huovinen, 1999). In the UK ESBL E. coli isolates 367 
from chicken and turkey production were found to be distinct from those causing disease in humans 368 
(Randall, et al., 2010), although transfer of AMR might be occurring between the two. Vancomycin 369 
resistant enterococci (VRE) detected in German minced pork and beef were different to clinical 370 
isolates (Klein, Pack, & Reuter, 1998). 371 
Another means of linking human colonisation with food consumption is by using a case-372 
control approach. For relatives of cases with community-acquired urinary tract ESBL-producing E. 373 
coli eating outside of the home was shown to be protective, which might imply that eating at home 374 
was a risk factor which, in turn, might imply cross contamination within the home (Rodríguez-Baño, 375 
López-Cerero, Navarro, Díaz de Alba, & Pascual, 2008). A comparison of vegetarians and newly 376 
hospitalised patients in the USA focused on risk factors for colonisation by AMR E. coli  (Sannes, et 377 
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al., 2008). Poultry meat contact and/or consumption was not predictive, and vegetarians were more 378 
frequently colonised by AMR E. coli. Travel and recent visits to a “developing nation” were risk 379 
factors. For campylobacteriosis in Denmark, risk factors for quinolone resistant infections included 380 
foreign travel, eating poultry other than chicken and turkey, and swimming. Eating chicken was 381 
protective (Engberg, Neimann, Nielsen, Aarestrup, & Fussing, 2004). In contrast poultry consumption 382 
and touching raw poultry were risk factors for colonisation by Ent. faecium with inducible 383 
quinupristin-dalfopristin resistance (Kieke, et al., 2006). 384 
Tracking of antibiotic resistant E. coli and Salmonella in the beef production chain in America 385 
found that resistant organisms could be detected on hides, decreasingly present along the chain, 386 
and they were not present in 103 striploin purge samples at the end of production (Schmidt, et al., 387 
2015). In another study the diversity of AMR genes reduced during meat processing with no AMR 388 
genes present on beef products (Noyes, et al., 2016). Similarly the prevalence of AMR bacteria was 389 
greater, when differences were noted, on vegetables obtained from the farm compared to those 390 
tested at retail (Schwaiger, et al., 2011). In Italy, resistant Enterobacteriaceae were present in 52.2% 391 
of pig rectal swab isolates, but in only 3% of minced pork isolates, and the species composition was 392 
different (Sabia, et al., 2017). Similar data were produced for Canadian samples where the 393 
prevalence of MRSA was 61.9% in nasal swabs reducing to 1.2% in retail pork (Aslam, Diarra, 394 
Checkley, Bohaychuk, & Masson, 2012). Italian data demonstrated a reduction of AMR bacteria in 395 
traditional mozzarella production, with the final product containing no AMR bacteria (Devirgiliis, 396 
Caravelli, Coppola, Barile, & Perozzi, 2008). It would be expected that the prevalence of AMR 397 
organisms of a given species would decline along the food chain in tandem with general increases in 398 
food hygiene.  399 
Most reports of the presence of AMR bacteria in foods do not provide prevalence or 400 
concentration data for particular types of resistant bacteria. Usually they provide data on the 401 
proportion of isolates of a given taxon which are resistant to different panels of antibiotics 402 
(Schroeder, White, & Meng, 2004), and use different criteria to define what constitutes resistance. 403 
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These data therefore need further processing and interpretation if they are to be used in exposure 404 
assessments.  405 
Example papers and summary information on the prevalence of AMR bacteria in raw (Table 406 
2) and ready-to-eat (RTE) foods are provided (Table 3). In addition, a recent review commissioned 407 
for the UK Food Standards Agency provides prevalence data for AMR Campylobacter, Salmonella, E. 408 
coli and Enterococcus in pork, poultry, dairy products, seafood, and vegetables and fruit (Royal 409 
Veterinary College, 2016).  It would be expected that the prevalence of pathogens in raw food would 410 
be higher than in RTE/cooked foods, but there is no reason for the proportion of AMR among 411 
isolates from the two kinds of food to be different unless, for example, AMR also conferred 412 
resistance to a physico-chemical characteristic used in food processing. It has been shown that AMR 413 
does not confer additional cross resistance to L. monocytogenes in respect to survival at high or low 414 
pH (Cunha, et al., 2016). 415 
…………………………… 416 
Table 2 about here 417 
……………………………. 418 
……………………………… 419 
Table 3 about here 420 
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 422 
AMR organisms have been isolated in high concentrations in a variety of foods (Boehme, 423 
Werner, Klare, Reissbrodt, & Witte, 2004; Rodríguez, et al., 2006; Wang, et al., 2006). However, 424 
there is a need for some caution when considering these data. For example cefotaxime-resistant L. 425 
monocytogenes are common among isolates from food, but this resistance is natural since it results 426 
from the lack of a specific penicillin binding protein (Yan, et al., 2010). Other organisms are, likewise, 427 
naturally resistant to certain antibiotics (Fitzgerald, et al., 2011; Haubert, et al., 2016) and so the 428 
identification of generic AMR bacteria in a food may be of little or no consequence, especially if the 429 
resistance is not capable of undergoing HGT. 430 
Outbreaks of foodborne disease caused by AMR pathogens are known to occur (Dechet, et 431 
al., 2006). For example an outbreak of 58 cases of multidrug-resistant Salmonella Typhimurium DT 432 
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104 infections associated with the consumption of contaminated minced beef.  The same serovar of 433 
Salmonella also caused an outbreak  in Denmark of 25 culture confirmed cases of whom 11 were 434 
hospitalised and two died (Mølbak , et al., 1999). The source was identified as two Danish pig herds. 435 
Interestingly the veterinarian claimed that fluoroquinolones had not been used on the farms yet the 436 
isolates were nalidixic acid resistant. The consequence of infection by AMR pathogens to humans are 437 
more severe than infection by their susceptible counterparts, including higher mortality rates 438 
(Helms, Vastrup, Gerner-Smidt, & Mølbak, 2002) and duration of illness (Engberg, et al., 2004). 439 
The consumption of a contaminated food could result in foodborne disease caused by 440 
antibiotic-resistant variants of foodborne pathogens such as Salmonella (Su, et al., 2004) and 441 
Campylobacter (Zhao, et al., 2015). Different modelling exercises have resulted in very different 442 
estimates of risk, but the potential for AMR transmission by this route must be considered as 443 
possible (Chang, Wang, Regev-Yochay, Lipsitch, & Hanage, 2015). A review of publically available risk 444 
assessments concerning the use of antimicrobials in animal production and the emergence of AMR 445 
infections in humans has been published (McEwen, 2012). A great deal of heterogeneity of approach 446 
was noted, making comparisons difficult, and a lack of necessary data was noted. Differences in the 447 
outcomes of risk assessment will therefore reflect real differences, as well as differences in the 448 
availability of data and approach taken. A later discussion paper describes the data needs and 449 
complexities of carrying out a holistic human health risk assessment for AMR bacteria (Ashbolt, et 450 
al., 2013), which would be a larger task than a standard quantitative risk assessment for a defined 451 
food/hazard combination. A Swiss semi-quantitative risk assessment did, however, compare relative 452 
risks of AMR bacteria in chicken, beef, pork and veal (Presi, et al., 2009), and the order was (in % “of 453 
the overall risk”) was chicken (6.7%), pork (4.0%), beef (0.4%) and veal (0.1%). 454 
Another potential source of contamination of foods by AMR bacteria is contact with infected 455 
food handlers at any point in the food chain. This may be especially important for AMR 456 
Staphylococcus aureus where it is known that the strains of the organism involved in human 457 
foodborne disease are those introduced onto food during handling, as opposed to strains present on 458 
19 
 
the food animal (Hudson, 2014), although livestock associated strains can be isolated from foods 459 
(Fox, et al., 2017). This is reflected in a study of MRSA in minced beef and pork in the USA which 460 
concluded that some of the MRSA present in beef were introduced by human contact (Jackson, 461 
Davis, & Barrett, 2013) and may represent a source of infection for consumers of that beef. This 462 
possible transmission route was attributed to a fatal hospital outbreak of MRSA infections where an 463 
infected health care worker was concluded to have contaminated food eaten by affected patients, 464 
and subsequent transmission occurred (Kluytmans, et al., 1995). 465 
Foods produced from animals treated with antimicrobials may themselves contain residual 466 
concentrations of them and such foods are subject to testing programmes. Some data are reported, 467 
but results for other samples which contain antimicrobials but at concentrations beneath regulatory 468 
maxima are not necessarily reported. Foods containing antibiotics may therefore act as niches for 469 
the selection of AMR bacteria which are capable of growing on them under normal storage 470 
conditions. In the UK a survey of waste milk (which can be derived from animals being treated with 471 
antimicrobials) samples for β-lactam antibiotics found that 66/103 (64.1%) contained at least one 472 
member of the antibiotic groups penicillins and cephalosporins (Randall, et al., 2014). The maximum 473 
concentration was 4.6 mg/l cefquinome which was also detected up to 27 mg/l in a follow up study. 474 
The presence of antimicrobials was correlated to reported antibiotic use in the herds tested. Culture 475 
for AMR bacteria found that resistant bacteria were 20 times more likely to be present in 476 
cefquinome-containing milk. The use of waste milk to feed calves has been proposed as an 477 
explanation for why AMR E. coli gradually decreases during fattening once exposure to the milk has 478 
been removed (Hordijk, et al., 2013). 479 
A study of the accumulation of antimicrobials by vegetables has shown that the leaves 480 
accumulate the most (Hu, et al., 2010). The paper also reported values for antimicrobials in various 481 
herb and vegetable plants finding 10 of the 11 antimicrobials sought to be present, and their origin 482 
was likely to be organic fertilisers applied to growing crops. It has been found that the presence of 483 
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antimicrobials at even low concentrations (several hundred fold less than the lethal concentration) 484 
can lead to the selection of resistant bacteria (Sandegren, 2014). 485 
 486 
3.2 Non-Food Transmission Routes associated with the agri-food chain 487 
AMR bacteria may be excreted in the faeces to contaminate the wider environment. Therefore non-488 
food environmental transmission routes may result from antimicrobial use in food production. 489 
Transmission might occur via environmental contamination (e.g. manure to water to humans) 490 
(Thanner, Drissner, & Walsh, 2016) or via insects, such as flies, to ready-to-eat foods (Zurek & Ghosh, 491 
2014). The incidence of campylobacteriosis appears to be correlated with fly development time in 492 
the UK (Nichols, 2005). A high throughput sequencing study of the resistome of feedlot cattle 493 
showed “environmental connectivity” between pens and feedlots indicating the potential for 494 
transmission to humans through the environment (Noyes, et al., 2016). 495 
Food contact surfaces may also become contaminated. In Malaysian wet markets 38.8% of 496 
poultry contact surfaces were contaminated with Extended Spectrum β-Lactamase-producing (ESBL) 497 
E. coli (Aliyu, Saleha, Jalila, & Zunita, 2016). Logistic regression analysis identified two factors which 498 
predicted the contamination of poultry; stall sanitation and counter top material, with wood 499 
associated with the greatest risk. Interestingly, cross-resistance to antimicrobials resulted from 500 
exposure to increasing concentrations of quaternary ammonium compounds in Salmonella and, to a 501 
greater extent, E. coli, but not in L. monocytogenes or C. coli (Soumet, et al., 2016) indicating that 502 
food processing sanitation operations could lead to co-selection  of AMR bacteria which could then 503 
contaminate foods. A similar variability in the potential for cross-resistance to occur has been found 504 
for E. coli and enterococci (Wieland, et al., 2017). 505 
Transmission of AMR Staphylococcus aureus (methicillin-resistant S. aureus, MRSA, which is 506 
resistant to penicillins and cephalosporins) can occur via direct contact between livestock and 507 
humans, with potential subsequent person-to-person transmission. The dynamics of the spread of 508 
MRSA between humans and pig herds have been shown for one particular genotype, although in this 509 
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case the direction of transmission appeared to be from humans to animals (Grøntvedt, et al., 2016). 510 
A review of livestock-associated MRSA reported that 77-86% of those with occupational exposure to 511 
colonised pigs will themselves be colonised in the nasal cavity (Cuny, Wieler, & Witte, 2015) and 512 
further transmission can result in 3% of nosocomial MRSA infections and higher proportions of 513 
septicaemia and wound infection cases. An analysis of clonal complex 398 MRSA cases found that 514 
contact with livestock and residence on a pig farm were risk factors (Deiters, Günnewig, Friedrich, 515 
Mellmann, & Köck, 2015). For those cases without livestock contact there were still livestock-516 
associated risk factors, as well as risk factors such as prior hospital stays and contact with MRSA 517 
carriers. Butchers have also been shown to be colonised by livestock associated MRSA (Boost, Ho, 518 
Guardabassi, & O'Donoghue, 2013). There are flows between humans and pigs in both directions as 519 
well as person-to-person transmission of MRSA, but the evidence for foodborne transmission is not 520 
apparent.  521 
Another potential route might be the HGT of resistance genes from foodborne commensal 522 
or starter bacteria to recipient cells in the guts, as shown in humans (Devirgiliis, Barile, & Perozzi, 523 
2011; Huddleston, 2014) and mice (Sparo, et al., 2012). Ingestion of AMR E. faecium isolates resulted 524 
in transient colonisation of human volunteers, and all twelve were clear of their inoculum 35 days 525 
post exposure (Sørensen, et al., 2001), and only one person was shedding 14 days post-exposure. 526 
The organism could be isolated at concentrations up to 107-108/g faeces, depending on the strain. 527 
The potential for AMR strains to be present for significant periods and high concentration in the gut 528 
was therefore shown. 529 
4. Farmer and stakeholder behaviour and AMR  530 
 531 
It has been noted that, as part of the process of developing effective policy interventions to combat 532 
the emergence of AMR, the (interactive) behaviours of multiple actors, including farmers, but also 533 
veterinarians, policy makers and the public, result in antimicrobials being used either to facilitate or 534 
restrict the development of resistance to important drugs in both animals and humans (Garforth, 535 
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2015). However, there is a limited empirical evidence base to help understand the relevant issues, 536 
the most relevant being the understanding of farmer and veterinarian behaviours in relation to 537 
decision-making associated with antimicrobial use and AMR (Morris, Helliwell, & Raman, 2016). 538 
Understanding societal drivers of, and responses to, the restricted prescription of antimicrobials in 539 
human medicine is more extensive. Garforth (2015) notes that classical agricultural economics 540 
would predict that farmers only make decisions based on net income or profit,  However, this is not 541 
supported by the associated evidence base. Understanding the relative importance of financial 542 
incentivisation for farmer antimicrobial usage, as opposed to other motivating factors, is important 543 
as it will allow the development of policy interventions targeting the drivers of farmer behaviour. 544 
Farmers are the ultimate decision makers when deciding whether to use antimicrobials as 545 
part of animal production practices, and they may subsequently put pressure on other agricultural 546 
stakeholders to maintain existing animal husbandry practices which are reliant on antimicrobial use 547 
(Speksnijder et al, 2015).  Understanding the behaviours of all stakeholders is central to developing 548 
effective policy interventions targeting farmer use of antimicrobials. Farmer decision-making may be 549 
motivated by multiple sets of values, for example in relation to traditional practices, or the 550 
embedding of the farm itself within the social structure of the family (Gasson, 1973). However, farm 551 
businesses need to be profitable to survive, which arguably may incentivise greater use of 552 
antimicrobials on farms. In reality, the evidence regarding financial incentivisation is somewhat 553 
mixed. For example, Speksnijder, Jaarsma, van der Gugten, Verheij, and Wagenaar (2015) suggest 554 
that economic factors are an important driver of whether farmers put pressure on veterinarians to 555 
prescribe antimicrobials. In this context, they report that some farmers perceive diagnostic tests as 556 
expensive, and that preventive use of antibiotics is a financially “safer” option. An additional 557 
pressure on veterinarians is the perception that farmers will blame them for not prescribing 558 
preventative antimicrobials if animal diseases arise at a later date, with concomitant impacts on 559 
animal welfare and/or economic functioning of the farm (Gibbons, et al., 2012). In addition, farmers 560 
may be unwilling to change existing animal husbandry practices, which they perceive have resulted 561 
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in risk avoidance, or because they are unaware of the benefits of adopting alternative strategies 562 
(Gunn, Heffernan, Hall, McLeod, & Hovi, 2008; Klerkx & Jansen, 2010). Coyne, et al. (2016) explored 563 
the drivers and motivators behind antimicrobial use and prescribing by veterinary surgeons and 564 
farmers in the pig industry in the UK. The results indicated that veterinarians responded to pressure 565 
from clients, legislation and public perception when deciding whether to prescribe antibiotics. In 566 
contrast, farmers may consider issues surrounding farming systems and management to be 567 
important drivers of antimicrobial use. Lack of awareness of the consequences of inappropriate or 568 
overzealous use of antimicrobials may also be a driver of farmer decision-making.  For example, 569 
Friedman, et al. (2007) report that most cattle farmers included in their South Carolinian sample 570 
(86%) were not concerned that overuse of antibiotics in animals could result in AMR, in particular 571 
failing to recognise that this could result in antibiotic resistance among farm workers.  572 
Understanding why different actors are making decisions will facilitate the development of 573 
effective communication interventions targeting different stakeholder groups. While this is by no 574 
means only driven by economic motivation, it needs to be considered as part of  a broader set of 575 
potentially interacting socio-economic and animal production system related drivers, including, inter 576 
alia, lack of knowledge about the effects of antimicrobials, and motivations for using antimicrobials 577 
as a preventative measures. Both factors may link to understandings of animal welfare in the context 578 
of animal husbandry, in particular in relation to disease prevention, and represent a driver of social 579 
pressure to use and prescribe antimicrobials. It is also important to note that AMR represents a 580 
transboundary risk (Gebreyes , et al., 2014; You, Bong, & Lee, 2016), which does not respect 581 
regulatory or national barriers to migration to other regions or areas. Communication needs to 582 
address stakeholder and end-user requirements in different geographical locations, which requires 583 
not only international cooperation across policy and industry communities, but harmonisation of 584 
cultural, regulatory and policy objectives, and animal production system requirements 585 
internationally. Furthermore, an important policy objective is to ensure that a critical mass of 586 
individuals are  changing use behaviours to reduce the risks of AMR, and prevent economic 587 
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disadvantages and production losses having a negative impact on affecting  compliant farmers alone. 588 
The question of whether policies focused on incentivisation, for example, subsidizing farmers who 589 
can demonstrate appropriate use of antimicrobials, or enforcement (e.g. financial penalties  for non-590 
compliance following AMR testing) is the optimal approach to ensure effective risk mitigation 591 
measures are implemented requires further investigation. Without international harmonisation of 592 
approaches any risk mitigation policies may remain ineffective (Kendall, et al., Submitted). 593 
 594 
4.1 Illegal use of antimicrobials 595 
 596 
Although more difficult to assess from the perspective of famer behaviour, and an issue representing 597 
a difficult policy dilemma, the issue of illegal use needs to be addressed (Donoghue, 2003). There are 598 
examples in the literature demonstrating that illegal antimicrobial administration is widespread.     599 
For example, feed and fish from an aquaculture farm in eastern Sicily (Italy) were tested using 600 
commercial ELISA kits. Levels of antimicrobials exceeding the method's detection capability were 601 
found in all feed and tissue samples (Oliveri Conti, et al., 2015). In China, overuse and illegal use of 602 
antimicrobials across the entire farming sector are well documented (Hu & Cheng, 2016; Zhong, 603 
Huang, & Wu, 2017). Similar patterns of illegal use in animal production systems have been 604 
identified, inter alia, in Vietnam (Kim, et al., 2013), Cameroon (Gondam Kamini, Tatfo Keutchatang, 605 
Yangoua Mafo, Kansci, & Medoua Nama, 2016), and the US (Alvy, 2014). 606 
There are reports that illegal antimicrobial use is also prevalent in specific sectors, either as a 607 
preventative measure or a growth promoter. Prominent examples include within aquaculture 608 
(Tuševljak, et al., 2013) and pig sectors (Došen, et al., 2014). Regulatory and industry action is 609 
required to prevent illegal use: ignoring it may be viewed as supplying tacit approval (Morley, et al., 610 
2005). However, a major barrier to understanding the motivations for famers to use antimicrobials 611 
illegally is obviously that their use is illegal, and farmers are unlikely to be honest about illegal use 612 
and their motivations for doing so when interviewed by researchers. Monitoring illegal use may be 613 
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possible, but understanding why antimicrobials are being used, may represent a particularly difficult 614 
research problem. Answering it will require the application of social science research methods which 615 
guarantee the anonymity of participants, allow them to develop trust in researchers, and engage 616 
with the problems of AMR bacteria. 617 
 618 
4.2 The importance of effective communication 619 
 620 
A recent report, published by the UK Food Standards Agency (Royal Veterinary College, 2016), 621 
highlighted the need to adopt “clear transparent reporting standards that help consumers have 622 
access to and understand information about the responsible use of antibiotics in the food chain”. 623 
Increased consumer recognition of problems associated with antimicrobial usage may increase 624 
demand for products with certified and reduced antimicrobial use. Certain segments of the 625 
population may be willing to pay more for such products. For example, it has been proposed that 626 
labelling and marketing may demonstrate how policy makers can develop a verified antimicrobial-627 
free labelling program that would allow consumers to purchase meat products from animals that 628 
had never received antimicrobials, although this would require considerable risk communication and 629 
public education efforts to ensure that the general public  know the importance of the issue 630 
(Centner, 2016). Although there is a substantial body of literature focused on understanding 631 
consumer attitudes towards animal welfare and welfare indicators on products, the issue of 632 
antimicrobial use in animal production systems has not been extensively researched, (Clark, Stewart, 633 
Panzone, Kyriazakis, & Frewer, 2016) and, as a consequence, little is understood regarding the 634 
extent to which consumers prioritise their reduction nor are willing to pay for products produced 635 
from animals raised without the use of, or with reduced use of, antimicrobials. While there is 636 
evidence that consumers express concerns about the use of antimicrobials in animal production 637 
systems, for example in relation to farm animal welfare and food safety, concern about AMR has not 638 
been reported, although this may reflect the construction of investigative methodologies (i.e. the 639 
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question was not asked) rather than lack of consumer and societal concern about the issue. For a 640 
review please see (Clark, Stewart, Panzone, Kyriazakis, & Frewer, 2017). 641 
 642 
5 Mitigation and intervention strategies 643 
A number of alternatives/mitigation strategies have been proposed and these are summarised in 644 
Table 4. A detailed consideration of many potential interventions is given by Baquero, et al. (2015), 645 
and reviews of alternatives (Czaplewski, et al., 2016) and management options (Pruden, et al., 2013) 646 
published. 647 
……………………………………… 648 
Table 4 about here 649 
……………………………………… 650 
 651 
One strategy that is often highlighted in the literature is the cessation of use of antimicrobials as 652 
AGPs and allied to this a general reduction in their use whenever possible. However, there is 653 
conflicting evidence as to whether such bans result in a general decrease in AMR bacteria. The 654 
outcome may be determined by factors such as co-selection or a fitness cost to possession of the 655 
resistance gene. In co-selection multiple resistance determinants may be present on the same 656 
genetic structure such that if the selective pressure to one is removed then resistance may still be 657 
maintained if one of the other selective pressures endures. In contrast, vancomycin-resistant 658 
Staphylococcus aureus lacking mecA (methicillin resistance) was shown to out-compete an 659 
homologous strain which possessed the gene (Noto, Fox, & Archer, 2008) so here the sensitive strain 660 
should be selected for over the resistant one. Resistance to macrolides and glycopeptides did, 661 
however, reduce in Ent. faecium consistently between 1997 and 2003 following a ban on their use as 662 
growth promoters in 1995-1998 in Denmark (Hasman & Aarestrup, 2005).  663 
To know whether mitigations are effective it is necessary to have in place robust surveillance 664 
systems such that effects can be measured. Several national and international programmes releasing 665 
data online are now in existence, for example The National Antimicrobial Resistance Monitoring 666 
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System (NARMS) in the US7 and the European Antimicrobial Resistance Surveillance Network (EARS-667 
Net)8. However, currently such programmes may be disjointed, especially where they cross 668 
jurisdictions (McNulty, Soon, Wallace, & Nastasijevic, 2016). Clearly policy needs to be founded on 669 
reliable data, and so such data need to be compatible and use the same criteria (e.g. definition of 670 
“resistant”). Similarly policy needs to be based on a sound understanding “of those practices that are 671 
truly contributing to the antibiotic resistance problem (Singer & Williams-Nguyen, 2014).  672 
 673 
6 Economics of resistance 674 
 675 
The selection pressures leading to resistance are heavily influenced by the behavioural 676 
responses of individual actors who may not have an incentive to take into account the negative 677 
impact on the future effectiveness of antimicrobials being used. The costs and benefits of 678 
antimicrobial use and the magnitude of resistance can be estimated using economic approaches. 679 
However, economic analysis can go much further than this in understanding the evolution of 680 
resistance and developing policy responses. 681 
The response to resistance occurs on two fronts:  682 
1) Need to manage existing portfolio on antimicrobials to maximise the value from their use 683 
2) Develop new products to replace those that resistance has made ineffective 684 
These two strategies are linked, somewhat paradoxically, in that better use of existing products 685 
reduces potential returns from developing new products. 686 
The economics literature has considered antimicrobial effectiveness as a societal resource 687 
and how use of this resource might be optimised. As an example, in agricultural economics there has 688 
long been a consideration of the impacts of pesticide resistance. For example, Hueth and Regev 689 
                                                            
7 
https://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanc
eMonitoringSystem/  
8 http://ecdc.europa.eu/en/healthtopics/antimicrobial-resistance-and-
consumption/antimicrobial_resistance/EARS-Net/Pages/EARS-Net.aspx  
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(1974), considered pest susceptibility to pesticides as a non-renewable resource that is privately 690 
costless to use in the short run but very costly longer term to society when new products are 691 
required. Treating susceptibility as an exhaustible resource and the temporal mismatch between the 692 
costs and benefits of the product are central characteristics of the economic problem. 693 
The use of products to control harmful biological organisms has two side-effects neither of 694 
which is considered by users: 695 
 The effective use of the product by a farmer reduces the spread of the pest/disease elsewhere 696 
producing a positive outcome for other farmers; 697 
 On the negative side, the use of the product engenders greater resistance in the future  698 
Unless the perceived value of negative future impacts is greater than the value of disease 699 
reduction, end users will deploy the product at a greater level than is best from a societal 700 
perspective. The likelihood of a farmer using antimicrobials is a function of the perceived 701 
consequences of non-use, the probability of these consequences occurring, how effective the 702 
therapy is likely to be, and the cost (Lhermie, Gröhn, & Raboisson, 2016). In essence this suggests 703 
that, in economic terms, the farmer will use antimicrobials when it is profitable to do so (although 704 
see previous section on alternative drivers of farmer behaviour with respect to antimicrobial use).  705 
Veterinarians may profit from the sales of antimicrobials and this driver for potential over use can be 706 
negated by legislating for the reduction in such profits; in Denmark a 40% reduction in overall use 707 
between 1994 and 1995 resulted from such an action (Dar, et al., 2016). 708 
 709 
7 Conclusions 710 
The continued emergence of AMR bacteria will mean that infections which are currently treatable by 711 
the use of antimicrobials may become untreatable in the future. It seems clear that the rise of AMR 712 
is, in part, attributable to overuse of antimicrobials in the treatment of human diseases. However, 713 
the link between the emergence of AMR bacteria in food production and transmission through the 714 
food chain to potentially susceptible human hosts is less clear (Chang, et al., 2015) and described as 715 
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“a prominent and contentious issue” (Schmidt, et al., 2015). There is evidence, though, that the use 716 
of antimicrobials in animal production does result in an increase in the presence of AMR bacteria in 717 
food animals. The degree of subsequent transmission to humans is less clear. 718 
The AMR situation is more complicated than is the case for tracking contamination pathways 719 
of pathogenic bacteria in food production as account needs to be taken of the epidemiology of both 720 
the organisms containing AMR genes and the genes themselves, as part of the complexity lies in the 721 
ability of the genes to transfer between taxa. Commensal organisms in foods also have a role to play 722 
in conveying resistance from food production to human infections. More data to demonstrate, or 723 
otherwise, the flow of AMR bacteria/genes from food and/or the food production environment to 724 
clinical cases, and to provide data to satisfy the many identified data gaps (Thanner, et al., 2016) 725 
would provide much needed evidence to establish the size of the role of the agri-food chain in the 726 
transmission of AMR to humans. 727 
For food to transmit AMR bacteria the bacteria need to be present in the food in the first 728 
place, and the food industry goes to great lengths to ensure that food is prepared in as hygienic 729 
manner as possible, and free of bacterial pathogens. Some food is brought into the household raw 730 
and could therefor harbour AMR bacteria. For example, red meats may be contaminated by 731 
Salmonella or E. coli O157:H7. These foods are normally cooked prior to consumption, markedly 732 
reducing the risk but not eliminating it, as cross contamination might occur prior to cooking. The 733 
controls needed to prevent transmission of AMR bacteria via food are the same as those needed to 734 
control foodborne pathogens and spoilage organisms in toto and involve all stakeholders along the 735 
food chain, including everyone from the grower to the consumer. Data for the prevalence and 736 
concentration of AMR bacteria on ready-to-eat foods are scarce and to assist with exposure 737 
assessment the acquisition of such data should preferably focus on defined 738 
bacterium/phenotype/genotype combinations. Prevalence data would be of more use of they were 739 
expressed as the proportion of each food type containing the bacterium/gene in question instead of 740 
as a proportion of the isolates obtained from a variety of foods as granularity is lost when this is 741 
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done (although the data are no doubt available from the authors of such studies). To gain the 742 
maximum benefit data need to be collected in a consistent and comparable manner according to 743 
agreed and registered protocols. 744 
A recent review concluded that: 1) both the risks and benefits of the use of antimicrobials in 745 
animals need to be considered, 2) currently available data are inadequate to enable (1) to be 746 
considered properly and that,  3) relevant policy making is impaired because of this (Rushton, 2015). 747 
There does seem to be a bias in that often only the risks of AGP use are considered and 748 
comparatively little consideration of the benefits is given. A first step might be to assess the 749 
economics of AGP use, as well as the benefits and risks perceived by farmers and veterinarioans, 750 
including biological and socio-economic factors. If it is a cost then this will need to be countered by 751 
benefits such as animal welfare and reduced zoonoses. Reduction in the use of AGPs would seem to 752 
be of little use if the overall antimicrobial usage does not decrease in tandem, as seems to be the 753 
case in the EU, or at least for some countries. 754 
Generalisations in respect to control of AMR are very difficult to make as consistent patterns 755 
are hard to discern since particular organism/resistance combinations do not necessarily behave the 756 
same as one another and are driven by human behaviours which are poorly understood. This 757 
compounds the complex web of routes by which humans might become exposed/infected/colonized 758 
by AMR bacteria. Reducing the use of antimicrobials in animal production is unlikely to reduce MRSA 759 
infections of humans, for example. For some organism/gene combinations withdrawal of 760 
antimicrobials seems to be effective, and for others not. 761 
It was not the intent of this review to examine data on the emergence of AMR veterinary 762 
pathogens. However, it would be expected that if agricultural use of antimicrobials is causing AMR 763 
bacteria to become a problem in human clinical cases then the same should apply to veterinary 764 
pathogens. 765 
The transmission of AMR genes is a large and complex area involving agriculture, medicine, 766 
the environment, food and the interfaces of each with each other. Human behaviour, whether on 767 
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the part of farmers, veterinarians, other stakeholders, or consumer demand, represents an 768 
important driver of agricultural antimicrobial use and emergence of resistance. This complex picture, 769 
alongside the increasing recognition that there is a significant risk to human health, has meant that 770 
the volume of publications in this area has increased greatly. For example a search in Google Scholar 771 
for all of the words “antimicrobial resistance beef” anywhere in the article over the last 20 years 772 
returned publication numbers shown in Figure 2. Clearly it is not possible for a review to cover this 773 
volume of material and this in itself presents a problem with respect to understanding the 774 
complexities of the issue.  775 
………………………………… 776 
Figure 2 about here 777 
……………………………….. 778 
 779 
 780 
The large volume of literature and need for an interdisciplinary systems approach pose 781 
challenges for evidence synthesis which might be better met with structured model development 782 
than traditional systematic review and meta-analysis (Stewart, Meader, & Mengersen, 2014). 783 
Another potential approaches might include computer-based ways such as text mining. Text mining 784 
is useful when the volume of data available is so extensive that effective and efficient critical 785 
evaluation/review is impractical and/or very time consuming on a manual basis. Furthermore, text 786 
mining can provide the facility to add new knowledge and understanding quickly. An alternative to 787 
text mining would be the establishment of an AMR data repository with de facto pre-registration 788 
and use of common agreed outcome measurement, reporting and meta-language. This would 789 
address problems relating to selective reporting and publication bias in addition to facilitating access 790 
but would require increased investment in comparison to text mining. 791 
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Table 4. Some examples of potential alternatives/interventions to negate AMR bacteria. 
Alternative/intervention Effect Examples References 
Antibacterial peptides Alternative to antibiotics Structurally nanoengineered 
antimicrobial peptide polymers to treat 
Gram negative infections 
(Lam, et al., 2016) 
 
Antibodies 
 
Bind to and inactivate pathogens 
 
Avian Antibodies (IgY) 
 
(Kollberg, 2015) 
 
Bacteriophages 
 
Antimicrobial replacement 
 
Treatment of AMR Pseudomonas otitis 
 
(Wright, Hawkins, Änggård, & 
Harper, 2009) 
 
Competitive exclusion 
 
A benign bacterium is able to 
outcompete a pathogen 
 
Control of E. coli infections in weaned 
pigs 
 
(Harvey, Anderson, Genovese, 
Callaway, & Nisbet, 2005) 
 
Decontamination of 
waste/irrigation water 
 
Breaking the cycle of environmental 
transmission 
 
AMR bacteria have been detected in tap 
water and grew in the distribution system 
 
(Xi, et al., 2009) 
    
2 
 
Diagnostics Provide rapid information to aid 
decision making in antimicrobial 
prescription 
C-reactive protein testing to inform 
prescribing in lower respiratory tract 
infections 
(Cals, Schot, de Jong, Dinant, & 
Hopstaken, 2010) 
 
Incentives for 
stakeholders 
(farmers/veterinarians) 
 
 
Infection prevention and 
control interventions 
 
Phage endolysins 
 
Subsidies for appropriate AMR use; 
fines for inappropriate use; standards 
for traded foods; increased surveillance; 
retailer pressure 
 
Minimise the spread of pathogens 
regardless of antimicrobial susceptibility 
 
Antimicrobial replacement 
 
McDonald’s goal set in 2015 to “only 
serve chicken not treated with antibiotics 
important in human medicine” 
 
 
“all-in-all-out” animal rearing systems 
 
 
Various clinical applications to replace 
use of antibiotics and, for example, killing 
MRSA. For treatment of Gram positive 
infections. 
 
http://news.mcdonalds.com/us/
news-stories/2016/mcdonald-s-
usa-announces-big-changes-to-
its-food  
 
(Schuppers, et al., 2005) 
 
 
(Schmelcher, Donovan, & 
Loessner, 2012) 
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Probiotics/prebiotics/syn
biotics 
Improve animal health Treatment of Clostridium difficile 
infections 
(Lau & Chamberlain, 2016) 
 
 
Risk/benefit 
communication for 
consumers 
 
Use of alternative food 
animals 
 
Consumers drive demand for foods 
produced with reduced use of 
antimicrobials 
 
Hardier species need reduced 
applications of antibiotics to remain 
healthy 
 
Introduction of front of pack labelling, 
public education programmes  
 
 
Replacement of the black tiger shrimp 
with the white leg shrimp in Asian shrimp 
farms 
 
(Centner, 2016) 
 
 
 
(Rico, et al., 2013) 
 
Strategic use of 
antimicrobials 
 
Using antimicrobials in a controlled to 
stop emergence of AMR bacteria 
 
Prevent animal use of an antimicrobial 
while clinical resistance is rare 
 
(Smith, Harris, Johnson, 
Silbergeld, & Morris, 2002) 
 
Vaccination 
 
Prevents disease occurring and hence 
mitigates the need to use antibiotics 
 
Norwegian salmon industry 
 
(Burridge, Weis, Cabello, Pizarro, 
& Bostick, 2010) 
 
  
Figure 1. Example of the growth in AMR-related publications over the last two decades. The search 
was for all of the words “antimicrobial risk beef” anywhere in the record. 
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Figure 2. Comparison of the proportion of antibiotics prescribed for human use and sold for 
veterinary use. A positive number indicates a greater proportion sold for veterinary purposes. 
 
Table 1. A taxonomy of antimicrobial families 
Major Group Sub groups Site of action Examples 
β-lactams Penicillins Cell wall synthesis 
 
ampicillin, methicillin, penicillin G, amoxicillin 
Cephalosporins 1st generation: cefalothin, cefalonium 
2nd generation: cefuroxime 
3rd generation: cefotaxime, ceftriaxone, ceftiofur, 
ceftazidime 
4th generation: cefquinome 
Monobactams aztreonam 
Carbapenems ertapenem, imipenem, meropenem  
Aminoglycosides  Protein synthesis kanamycin, streptomycin, tobramycin, gentamicin, 
neomycin, amikacin, 
Sulphonamides  Folic acid synthesis sulphonamide, sulfamethoxazole, sulfamethazine, 
sulfamerazine, sulfadimethoxine 
Quinolones/Fluoroquinolones  DNA synthesis enrofloxacin, ciprofloxacin, levofloxacin, 
moxifloxacin, norfloxacin , nalidixic acid, 
flumequine, pefloxacin 
Macrolides  Protein synthesis azithromycin, clarithromycin, dirithromycin, 
erythromycin, azithromycin, clindamycin, tylosin, 
spiramycin, carbomycin, oleandomycin, 
kitsamycin, tiamulin 
Polypeptides  Cell membranes colistin, polymixin B, bacitracin 
Other: 
Glycopeptides 
 
 
Rifampin/Rifampicin 
 
Linezolid 
 
 
Tetracyclines 
 
Trimethoprim/ 
sulfamethoxacole 
 
Coccidiostats 
 
Streptograminins 
 
  
Cell wall synthesis (Gram 
+ve) 
 
RNA synthesis 
 
Protein synthesis (Gram 
+ve) 
 
Protein synthesis 
 
Folate synthesis 
 
 
Ionophore 
 
Protein synthesis 
 
 
avoparcin, vancomycin, teicoplanin, ardacin 
 
 
 
 
 
 
 
Tetracycline, doxycycline, oxytetracycline, 
chlortetracycline 
 
 
 
Lasolacid, monensin, salinomycin, narasin. Not 
used in human medicine. 
virginiamycin, quinupristin, dalfopristin (last two 
combined=synercid) 
 
TABLE 2. Examples of the Prevalence of AMR Isolates in Raw Foods 
Organism Food, country Criteria Number (%) of samples 
containing AMR bacteria and 
phenotype tested 
Reference 
Campylobacter Beef, Poland EUCAST 0 (0) N = 153 panel (Wieczorek, Szewczyk, & 
Osek, 2012) Pork, Poland 0 (0) N = 85 panel 
Escherichia coli Beef, UK http://eurl-
ar.eu/233-
protocols.htm  
2 (0.6) N=312 ESBL, AMPC (Animal and Plant Health 
Agency, 2016) Pork, UK 6 (2) N=312 ESBL, AMPC  
Chicken, Thailand Not related to 
external standards 
4 (29) N=14 ESBL (Boonyasiri, et al., 2014) 
Meat, Thailand 8 (31)N=26 ESBL 
Seafood, Thailand 0 (0) N = 9 ESBL 
Chicken, UK 
domestic 
Not related to 
external standards 
1 (2) N =62 CTX M ESBL enzymes (Warren, et al., 2008) 
Chicken, Imported 
into the UK 
Not related to 
external standards 
10 (37) N = 27 CTX M ESBL enzymes 
Retail poultry 
meat in wet 
markets, Malaysia 
CLSI 86 (54) N = 160 ESBL (Aliyu, et al., 2016) 
Minced meat, 
Austria 
EUCAST 20 (20) N = 100 ESBL (Petternel, et al., 2014) 
Retail chicken, 
Netherlands 
Not related to 
external standards 
92 (94) N = 98 ESBL (Leverstein-van Hall, et 
al., 2011) 
Enterobacteriaceae Minced pork, Italy CLSI 3 (0.5-1.5)1 N=200 AMPC 
0 (0) N =200 ESBL 
(Sabia, et al., 2017) 
Enterococcus faecium Conventional 
retail poultry, USA 
Antibiotic-free 
poultry, USA 
NCCLS 43 (56) N = 77 quinupristin-
dalfopristin R 
3 (13) N =23 
(Kieke, et al., 2006) 
Klebsiella spp. Chicken, Thailand Not related to 
external standards 
2 (22) N=9 ESBL (Boonyasiri, et al., 2014) 
Meat, Thailand 8 (31) N=26 ESBL 
Seafood, Thailand 4 (20) N=20 ESBL 
Vegetables, 
Thailand 
4 (15) N=15 ESBL 
Methicillin-resistant 
Staphylococcus aureus 
Minced meat, 
Austria 
EUCAST 9 (9) N = 100 (Petternel, et al., 2014) 
Beef products, 
USA 
CLSI 4 (4) N = 100 mecA (Jackson, et al., 2013) 
Pork products, 
USA 
CLSI 3 (3) N = 100 mecA 
Beef, Netherlands Not related to 
external standards 
42 (10.6) N = 395 (de Boer, et al., 2009) 
Veal, Netherlands 39 (15.2) N = 257 
Lamb/mutton, 
Netherlands 
20 (6.2) N = 324 
Pork, Netherlands 33 (10.7) N = 309 
Chicken, 
Netherlands 
83 (16.0) N = 520 
Turkey, 
Netherlands  
41 (35.3) N = 116 
Fowl, Netherlands 4 (3) N = 118 
Game, 
Netherlands 
4 (2) N = 178 
Beef, USA CLSI 0 (0) N = 29 (Hanson, et al., 2011) 
Turkey, USA 0 (0) N = 36 
Pork, USA 2 (4) N = 55 
Chicken, USA 0 (0) N = 45 
Beef, USA CLSI 1 (3) N = 38  (Waters, et al., 2011) 
Turkey, USA 1 (4) N = 26 
Pork, USA 1 (4) N = 26 
Chicken, USA 0 (0) N = 46 
Pork, USA CLSI 5 (6) N = 90 (Pu, Han, & Ge, 2009) 
Beef, USA 1 (3) N = 30 
Pork, Netherlands CLSI 2 (3) N = 64 (van Loo, et al., 2007) 
Beef, Netherlands 0 (0) N = 15 
Beef, USA CLSI 2 (1) N = 156 (Bhargava, et al., 2011) 
Chicken, USA 3 (4) N = 76 
Turkey, USA 1 (2) N = 57 
Chicken, UK EUCAST 4 (8) N = 50 (Fox, et al., 2017) 
Pork, UK 3 (5) N = 63 
Turkey, UK 2 (18) N = 11 
Salmonella Beef, Ireland Not related to 
external standards 
0 (0) N=22 (Duffy, et al., 1999) 
Lamb, Ireland Not related to 
external standards 
0 (0) N =10 
Minced beef, USA NCCLS 1 (2) N = 50 (White , et al., 2001) 
Live freshwater 
finfish, China 
CLSI 5 (5) N =100. All 5 resistant to 
erythromycin and penicillin 
(Broughton & Walker, 
2009) 
Vancomycin-resistant 
enterococci 
Minced meat, 
Austria 
EUCAST 0 (0) N =100 (Petternel, et al., 2014) 
Chicken, Turkey NCCLS 2 (8) N = 25 (Koluman, Akan, & 
Çakiroğlu, 2009) Beef, Turkey 0 (0) N = 25 
Spices, Turky 0 (0) N = 30 
Seafood, Spain NCCLS 0 (0) N = 24 (Valenzuela, Benomar, 
Abriouel, Cañamero, & 
Gálvez, 2010) 
Beef, Denmark (E. 
faecium) 
Not related to 
external standards 
0 (0) N = 1282 (Wegener, Madsen, 
Nielsen, & Aarestrup, 
1997) 
 
1 Between 0.5 and 1.5% of the samples were positive  
2 Enrichment was not used 
ESBL = extended spectrum β-lactamase producers 
AMPC = Class C β-lactamase producing 
N = number sampled tested 
NCCLS = National Committee for Clinical Laboratory Standards 
EUCAST = European Committee on Antimicrobial Susceptibility Testing 
CLSI = Clinical and Laboratory Standards Institute 
mecA = gene indication MRSA 
TABLE 3. Examples of the Prevalence of AMR Isolates in RTE Foods 
Organism Food, country Criteria Results (% of isolates resistant) 
and phenotype 
Reference 
Escherichia coli Lettuce leaves, 
Belgium 
CLSI 58 (22) N= 264 Antibiotic panel (Holvoet, Sampers, 
Callens, Dewulf, & 
Uyttendaele, 2013) 
Market foods, 
Thailand 
Not related to 
external standards 
2 (6.7) N= 30 ESBL (Boonyasiri, et al., 2014) 
Street vended 
hamburgers, 
Portugal 
CLSI/EUCAST 2 (20) N = 10; 1 R to tetracycline, 1 R to 
amoxicillin, chloramphenicol, 
streptomycin, sulfamethoxazole, 
tetracycline  
(Campos, Gil, Mourão, 
Peixe, & Antunes, 2015) 
Street vended 
hot dogs, 
Portugal 
2 (20) N = 10; 1 R to nalidixic acid, 1 R to 
amoxicillin, chloramphenicol, 
ciprofloxacin, streptomycin, kanamycin, 
nalidixic acid, tetracycline, trimethoprim 
Listeria spp. Retail foods, 
Turkey 
Not related to 
external standards 
13 (13) N = 100. All S to 
chloramphenicol, trimethoprim, 
tetracycline and tobramycin; all R to 
rifampicin 
(Şİrelİ & Gücükoğlu, 
2008) 
Vegetable 
products, Brazil 
CLSI 2 (2) N = 132. R to Penicillin G and 
tetracycline.  S to cefoxitin, 
ciprofloxacin, erythromycin, 
streptomycin, oxacillin, vancomycin 
(de Vasconcelos Byrne, 
Hofer, Vallim, & de 
Castro Almeida, 2016) 
Dairy products CLSI 0 (0) N = 65 (Chen, Wu, Zhang, Yan, & 
Wang, 2014) Cold noodles in 
sauce 
0 (0) N = 24 
 
Cooked beef 0 (0) N = 3 
Miscellaneous 
ready-to eat 
foods 
N/A (1) N = 131 
Salmonella Retail turkey 
products, USA 
NARMS/FDA 6 (1) N =614 R ≥ 2 antibiotics (Khaitsa, Kegode, & 
Doetkott, 2007) 
Vancomycin resistant 
enterococci 
Cheese (different 
types), Turkey 
NCCLS 0 (0) N =50 (Koluman, et al., 2009) 
Yoghurt 0 (0) N =20 
RTE cooked foods 0 (0) N = 50 
 
N = number sampled tested R resistant S susceptible 
NCCLS = National Committee for Clinical Laboratory Standards 
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